comparemela.com

Latest Breaking News On - Lund may - Page 1 : comparemela.com

Active Biotech: FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis. "The

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.